Rapidly Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in NSCLC Cell Lines through De-Repression of FGFR2 and FGFR3 Expression

Lignende værker

• The Fibroblast Growth Factor Receptor Signaling Pathway as a Mediator of Intrinsic Resistance to EGFR-specific Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer
  af: Kono, Scott A., et al.
  Udgivet: (2009)
• A tyrosine kinase inhibitor-induced interferon response positively associates with clinical response in EGFR-mutant lung cancer
  af: Gurule, Natalia J., et al.
  Udgivet: (2021)
• High expression of hypoxia inducible factor 1α related with acquired resistant to EGFR tyrosine kinase inhibitors in NSCLC
  af: Jin, Qian, et al.
  Udgivet: (2021)
• De-repression of PDGFRβ transcription promotes acquired resistance to EGFR tyrosine kinase inhibitors in glioblastoma patients
  af: Akhavan, David, et al.
  Udgivet: (2013)
• Management of acquired resistance to EGFR kinase inhibitors in advanced NSCLC
  af: Sacher, Adrian G., et al.
  Udgivet: (2014)